Improving access to radiotheranostics for cancer patients in the US
The Oncidium foundation promotes and supports access, education, and hope for radiotheranostic-based treatments, an emerging modality in cancer care.
In Cary’s final years, he became both an advocate for and personally participated in research of radiotheranostic treatments for cancer care. Cary interacted with the Oncidium Foundation about:
- Enhancing patient Access to radiotheranostic cancer treatments and clinical trials
- Raising awareness about radiotheranostics via Educational programs
- Building Hope by supporting the development of new radiotheranostic treatments
for patients with limited options.
The Cary M. Adams Fund, opened in collaboration with the Oncidium foundation, will be used for projects in the US to continue Cary’s commitment to enhancing cancer patients’ access, raising awareness, and supporting the development of new radiotheranostic treatments.
How do I donate?
You can demonstrate your support for Cary and his legacy by visiting the Cary M. Adams Fund website via the Oncidium foundation DONATE page.
This fund is a 501(c)(3) tax-exempt fund, where donors may claim the maximum tax benefits allowed by U.S. tax law for their contributions.µ
>> Questions about Cary and his legacy can be directed to Healy Adams Oppenheimer at: firstname.lastname@example.org